Yu Wang
Shanghai, 200443, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Development of Predictive Models for NB-UVB Treatment Efficacy and Safety in Psoriasis.
Journal: Psoriasis (Auckland, N.Z.)
Published: March 17, 2026
Higher body weight in Chinese patients is associated with treatment resistance to fixed-dose interleukin-17 inhibition with ixekizumab but not to weight-adjusted secukinumab therapy.
Journal: Journal of the American Academy of Dermatology
Published: September 13, 2025
Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis.
Journal: Psoriasis (Auckland, N.Z.)
Published: June 04, 2025
Comparative Effectiveness of Ixekizumab Versus Ustekinumab in Patients With Psoriasis: A Randomized Controlled Trial Replication Using Data From an Observational Study (Shanghai Psoriasis Effectiveness Evaluation Cohort).
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: May 28, 2025
The Impact of Family History on Clinical Presentation and Biologic Treatment Response in Patients with Psoriasis: A Multicenter Prospective Cohort Study.
Journal: American journal of clinical dermatology
Published: January 07, 2025
Comparative effects of biologics on anxiety and depression symptoms in psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 08, 2024
N6-methyladenosine modification-tuned lipid metabolism controls skin immune homeostasis via regulating neutrophil chemotaxis.
Journal: Science advances
Published: October 02, 2024
Associations of exposure to acrylamide and glycidamide with psoriasis among adults: Findings from a population-based study.
Journal: Ecotoxicology and environmental safety
Published: September 24, 2024
Triple oxygen isotope reveals insolation-forced tropical moisture cycles.
Journal: Science advances
Published: September 11, 2024
Early inadequate response to biological agents portends treatment failure at 6 months in patients with psoriasis: A multicenter, prospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: August 21, 2024
Disagreement between physicians' and patients' assessment of disease activity in psoriasis: The SPEECH registry study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 04, 2024
A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis.
Journal: Journal of translational medicine
Published: October 26, 2023
Last Updated: 09/26/2026